Please login to the form below

Not currently logged in
Email:
Password:

Richard Paulson joins Ipsen as CEO for North America

He also becomes an executive vice-president at the French biopharma

Richard PaulsonIpsen has appointed Richard Paulson as executive vice president and chief executive officer of North America, roles that will see him take responsibility for all commercial operations throughout the region.

Paulson, who joins from Amgen where he most recently served as vice president and general manage of he oncology business unit, will report directly to David Meek, Ipsen’s chief executive officer.

Meek said: “We are extremely delighted to welcome Richard to Ipsen to drive the continued growth of our North American business and further our development as a leading biopharma company focused on innovation and speciality care.

“Richard brings a wealth of great leadership experience, vision, and a track record of exceptional execution in leading growing businesses, both in the US and internationally.”

During a 10-year career at Amgen, Paulson held a number positions at the company, including general manager of Germany and general manager of central and eastern Europe.

Prior to his time at Amgen, Paulson served in many general management, marketing and market access positions at Pfizer.

He said: “I am honoured to join Ipsen at this time of rapid transformation and growth as the company progresses in its evolution as a leading global biopharma company.”

Paulson succeeds Cynthia Schwalm, who leaves Ipsen to pursue other interests.

19th January 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...
Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...

Infographics